Remo treatment dose-dependently improved these markers
It is not intended for human or veterinary use, diagnosis, treatment, cure, mitigation, or prevention of any disease or medical condition
Glucagon-like peptide-1 receptor agonist in myocardial infarction and atherosclerotic cardiovascular disease risk reduction: a comprehensive meta-analysis of number needed to treat, efficacy and safety
(2017) 4(1):ENEURO.0380-16.2017
The GLP-1 receptor agonist liraglutide improves memory function and increases Hippocampal CA1 neuronal numbers in a senescence-accelerated mouse model of Alzheimers disease
Minor side effects such as injection site pain, redness, or temporary headache are common and usually self-limiting